A single infusion of an experimental gene-editing drug appears safe and effective for cutting cholesterol, possibly for life, according to a small early study released Saturday.
The study, which involved 15 volunteers, found one infusion of a drug that uses the CRISPR gene-editing technique could safely reduce cholesterol, as well as levels of harmful triglycerides, by about half.
"Rather than a lifetime worth of medicine, we have the potential to give people a cure," said Dr. Luke Laffin, a preventative cardiologist at the Cleveland Clinic who helped conduct the study. "It's very exciting."
The results of the study were presented Saturday at the American Heart Association's annual meeting and published in The New England Journal of Medicine.
Health Glance
Cancer continues to be one of the world's top causes of death, due in part to delayed discovery of the disease. But according to a recently released study, a simple blood test may be able to identify a variety of cancers in their early stages.
A deadly listeria outbreak connected to prepared pasta meals sold at grocery chains nationwide is worsening, federal health officials say.
One of the monkeys that escaped after a truck overturned on a Mississippi roadway on 28 October was shot and killed early Sunday by a homeowner who said she feared for the safety of her children.
A group of ice cream makers that produce 90% of the nation’s ice cream and frozen dairy desserts are pledging to eliminate many artificial food dyes from their offerings by the end of 2027.
Health Secretary 





























